封面
市场调查报告书
商品编码
1704162

2025年全球DNA微阵列市场报告

DNA Microarray Global Market Report 2025

出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年 DNA 微阵列市场将快速成长。到 2029 年,这一数字将成长至 59.8 亿美元,复合年增长率为 12.1%。预测期内的成长可归因于个人化医疗的发展、比较基因组杂合反应(CGH) 的出现、农业基因组学的扩展、监管部门的核准、标准化以及慢性病盛行率的上升。预测期内的关键趋势包括基因组学研究的进步、基因组学研究资金的增加、技术创新、与其他技术的融合以及技术进步。

个人化医疗的快速应用是推动DNA微阵列市场成长的关键因素。个人化医疗根据每位患者的个别情况制定治疗方案,同时考虑他们的遗传、环境和生活方式因素,以提高治疗效果。由于「体学」技术、遗传学和资料整合的进步,这种方法已成为人们关注的焦点,并且个人化用药和预防措施的重要性也得到了认可。 DNA微阵列在个人化医疗中至关重要,它可以分析基因表现模式,根据个人的基因组成设计客製化的治疗方法。据美国非营利组织个人化医疗联盟称,2024年2月,FDA核准了16种新的罕见疾病个人化治疗方法,较2022年核准的6种有显着增加。因此,个人化医疗的快速应用正在推动DNA微阵列市场的扩张。

为了获得竞争优势,DNA 微阵列市场的主要企业正专注于开发仅需两天週转时间的先进技术。微阵列分析可在两天内获得结果,确保快速有效的结果,加速研究和临床决策流程。例如,美国生技公司赛默飞世尔科技于2023年8月宣布推出Applied Biosystems CytoScan HD Accel阵列。凭藉着业界领先的两天週转时间,这款新型染色体微阵列将提高细胞遗传学实验室的生产力、效率和盈利。 CytoScan HD Accel 阵列透过提供超过 5,000 个关键基因组区域的增强覆盖率实现全基因组分析,为产前、产后和肿瘤学研究中的各种应用提供对染色体变异的深入了解。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景,包括利率、感染疾病、地缘政治、新冠疫情、经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 世界DNA微阵列PESTEL分析(政治、社会、技术、环境、法律因素、驱动因素与限制因素)
  • 最终用途产业分析
  • 全球DNA微阵列市场:成长率分析
  • 全球 DNA 微阵列市场表现:规模与成长,2019-2024 年
  • 全球 DNA 微阵列市场预测:规模与成长,2024-2029 年,2034 年
  • 全球 DNA 微阵列总可定址市场(TAM)

第六章市场区隔

  • 全球 DNA 微阵列市场:按类型、性能和预测,2019-2024 年、2024-2029 年、2034 年
  • 互补DNA微阵列
  • 寡核苷酸DNA微阵列
  • 其他类型
  • 全球 DNA 微阵列市场:按应用、性能和预测,2019-2024 年、2024-2029 年、2034 年
  • 基因表现分析
  • 基因分型
  • 其他用途
  • 全球 DNA 微阵列市场:依最终使用者、绩效及预测,2019-2024 年、2024-2029 年、2034 年
  • 製药和生物技术公司
  • 诊断中心
  • 医院和诊所
  • 学术研究所
  • 其他最终用户
  • 全球 DNA 微阵列市场互补 DNA 微阵列细分(按类型)、实际及预测,2019-2024 年、2024-2029 年、2034 年
  • 基因表现
  • 比较基因组杂合反应(CGH)
  • 定量分析
  • 全球 DNA 微阵列市场依寡核苷酸 DNA 微阵列类型细分,实际状况及预测,2019-2024 年、2024-2029 年、2034 年
  • 基因表现微阵列
  • 单核苷酸多态性(SNP)阵列
  • DNA甲基化阵列
  • 病原体检测阵列
  • 全球 DNA 微阵列市场及其他细分市场,依类型、实际规模及预测,2019-2024 年、2024-2029 年、2034 年
  • 蛋白质-DNA微阵列
  • 组织微阵列
  • 亲和微阵列
  • 斑点DNA微阵列

第七章 区域和国家分析

  • 全球 DNA 微阵列市场:按地区、绩效及预测(2019-2024 年、2024-2029 年及 2034 年)
  • 全球 DNA 微阵列市场:依国家、表现及预测(2019-2024 年、2024-2029 年及 2034 年)

第八章 亚太市场

第九章:中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章:义大利市场

第20章:西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章:加拿大市场

第26章 南美洲市场

第27章:巴西市场

第28章 中东市场

第29章:非洲市场

第30章竞争格局与公司概况

  • DNA微阵列市场:竞争格局
  • DNA微阵列市场:公司简介
    • Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • PerkinElmer Inc.
  • Illumina Inc.
  • bioMerieux SA
  • Schott AG
  • Bio-Rad Laboratories Inc.
  • QIAGEN NV
  • Bioneer Corporation
  • CapitalBio Technology Co. Ltd.
  • Eurofins Genomics LLC
  • Savyon Diagnostics Ltd.
  • Oxford Gene Technology
  • Sengenics Corporation LLC
  • Affymetrix
  • BioCat GmbH
  • Scienion AG

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029 年 DNA 微阵列市场:提供新机会的国家
  • 2029 年 DNA 微阵列市场:细分领域带来新机会
  • 2029 年 DNA 微阵列市场:成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r30022

A DNA microarray is a potent instrument utilized in molecular biology to concurrently gauge the expression levels of numerous genes. It comprises small spots, termed probes, which contain established DNA sequences fixed onto a solid surface. When a sample containing DNA labeled with fluorescence is administered to the microarray, the fluorescence intensity at each spot reflects the expression level of the corresponding gene. This enables researchers to scrutinize gene expression patterns and pinpoint biomarkers linked with diverse diseases or experimental conditions.

The primary categories of DNA microarrays encompass complementary DNA microarrays, oligonucleotide DNA microarrays, and other variations. Complementary DNA serves as a robust research aid for assessing gene expression levels across a broad array of genes simultaneously. These microarrays find utility in gene expression analysis, genotyping, and various other applications, and are utilized by various end-users, predominantly pharmaceutical and biotechnology firms, diagnostic facilities, medical institutions, academic and research establishments, among others.

The DNA microarray market research report is one of a series of new reports from The Business Research Company that provides DNA microarray market statistics, including DNA microarray industry global market size, regional shares, competitors with a DNA microarray market share, detailed DNA microarray market segments, market trends and opportunities, and any further data you may need to thrive in the DNA microarray industry. This DNA microarray market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The DNA microarray market size has grown rapidly in recent years. It will grow from $3.38 billion in 2024 to $3.79 billion in 2025 at a compound annual growth rate (CAGR) of 12.3%. The growth in the historic period can be attributed to pharmacogenomics, healthcare infrastructure development, collaborations and partnerships, cost reduction, and public awareness and education.

The DNA microarray market size is expected to see rapid growth in the next few years. It will grow to $5.98 billion in 2029 at a compound annual growth rate (CAGR) of 12.1%. The growth in the forecast period can be attributed to growth in personalized medicine, the emergence of comparative genomic hybridization (CGH), expansion in agricultural genomics, regulatory approvals, and standards, and the rising prevalence of chronic diseases. Major trends in the forecast period include advancements in genomic research, increased funding for genomic studies, technological innovations, integration with other technologies, and technological advancements.

The rapid adoption of personalized medicine is a key factor fueling the growth of the DNA microarray market. Personalized medicine tailors medical treatments to individual patients, considering their genetic, environmental, and lifestyle factors to enhance treatment effectiveness. This approach has gained prominence due to advancements in 'omics' technology, genetics, and data integration, recognizing the significance of personalized medications and preventive measures. DNA microarrays are pivotal in personalized medicine, analyzing gene expression patterns to devise customized treatment approaches based on an individual's genetic composition. Notably, in February 2024, the FDA approved 16 new personalized therapies for rare diseases, a substantial increase from the 6 approved in 2022, according to the Personalized Medicine Coalition, a US-based non-profit organization. Thus, the swift adoption of personalized medicine serves as a driving force behind the expansion of the DNA microarray market.

Leading companies in the DNA microarray market are concentrating on developing advanced technology that offers a turnaround time of just two days to gain a competitive advantage. Microarray analysis with a two-day turnaround time ensures prompt and efficient results, accelerating both research and clinical decision-making processes. For instance, in August 2023, Thermo Fisher Scientific Inc., a US-based biotechnology firm, introduced the Applied Biosystems CytoScan HD Accel array. This new chromosomal microarray enhances productivity, efficiency, and profitability in cytogenetic research labs with its industry-leading two-day turnaround time. The CytoScan HD Accel array enables whole-genome analysis with improved coverage in over 5,000 key genomic regions, providing insights into chromosomal variants for various applications in prenatal, postnatal, and oncology research.

In May 2023, Thermo Fisher Scientific, a US-based scientific services company, formed a partnership with the Qatar Genome Program (QGP). This collaboration supports Thermo Fisher's dedication to advancing precision medicine, especially within Arab populations globally. As part of the partnership, Thermo Fisher and QGP will create a custom Axiom genotyping array, utilizing whole genome sequencing data from 19 Arab countries to further this initiative. The Qatar Genome Program (QGP) is a Qatar-based national population research project focused on genomic research.

Major companies operating in the DNA microarray market are Roche Holding AG, Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., bioMerieux SA, Schott AG, Bio-Rad Laboratories Inc., QIAGEN N.V., Bioneer Corporation, CapitalBio Technology Co. Ltd., Eurofins Genomics LLC, Savyon Diagnostics Ltd., Oxford Gene Technology, Sengenics Corporation LLC, Affymetrix, BioCat GmbH, Scienion AG, LC Sciences, Arrayit Corporation, Akonni Biosystems Inc., Arraystar Inc., Febit Holding GmbH

North America was the largest region in the DNA microarray market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the DNA microarray market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the DNA microarray market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The DNA microarray market consists of sales of DNA microarray chips, microarray scanners, and microarray printers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

DNA Microarray Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on dna microarray market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for dna microarray ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The dna microarray market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Complementary DNA Microarrays; Oligonucleotide DNA Microarrays; Other Types
  • 2) By Application: Gene Expression Analysis; Genotyping; Other Applications
  • 3) By End-user: Pharmaceutical And Biotechnology Companies; Diagnostic Centers; Hospitals And Clinics; Academic And Research Institute; Other End-Users
  • Subsegments:
  • 1) By Complementary DNA Microarrays: Gene Expression Profiling; Comparative Genomic Hybridization (CGH); Quantitative Analysis
  • 2) By Oligonucleotide DNA Microarrays: Gene Expression Microarrays; Single Nucleotide Polymorphism (SNP) Arrays; DNA Methylation Arrays; Pathogen Detection Arrays
  • 3) By Other Types: Protein-DNA Microarrays; Tissue Microarrays; Affinity Microarrays; Spotted DNA Microarrays
  • Companies Mentioned: Roche Holding AG; Thermo Fisher Scientific Inc.; Danaher Corporation; Merck KGaA; Agilent Technologies Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. DNA Microarray Market Characteristics

3. DNA Microarray Market Trends And Strategies

4. DNA Microarray Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global DNA Microarray Growth Analysis And Strategic Analysis Framework

  • 5.1. Global DNA Microarray PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global DNA Microarray Market Growth Rate Analysis
  • 5.4. Global DNA Microarray Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global DNA Microarray Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global DNA Microarray Total Addressable Market (TAM)

6. DNA Microarray Market Segmentation

  • 6.1. Global DNA Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Complementary DNA Microarrays
  • Oligonucleotide DNA Microarrays
  • Other Types
  • 6.2. Global DNA Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gene Expression Analysis
  • Genotyping
  • Other Applications
  • 6.3. Global DNA Microarray Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceutical And Biotechnology Companies
  • Diagnostic Centers
  • Hospitals And Clinics
  • Academic And Research Institute
  • Other End-Users
  • 6.4. Global DNA Microarray Market, Sub-Segmentation Of Complementary DNA Microarrays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gene Expression Profiling
  • Comparative Genomic Hybridization (CGH)
  • Quantitative Analysis
  • 6.5. Global DNA Microarray Market, Sub-Segmentation Of Oligonucleotide DNA Microarrays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gene Expression Microarrays
  • Single Nucleotide Polymorphism (SNP) Arrays
  • DNA Methylation Arrays
  • Pathogen Detection Arrays
  • 6.6. Global DNA Microarray Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Protein-DNA Microarrays
  • Tissue Microarrays
  • Affinity Microarrays
  • Spotted DNA Microarrays

7. DNA Microarray Market Regional And Country Analysis

  • 7.1. Global DNA Microarray Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global DNA Microarray Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific DNA Microarray Market

  • 8.1. Asia-Pacific DNA Microarray Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific DNA Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific DNA Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific DNA Microarray Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China DNA Microarray Market

  • 9.1. China DNA Microarray Market Overview
  • 9.2. China DNA Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China DNA Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China DNA Microarray Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India DNA Microarray Market

  • 10.1. India DNA Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India DNA Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India DNA Microarray Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan DNA Microarray Market

  • 11.1. Japan DNA Microarray Market Overview
  • 11.2. Japan DNA Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan DNA Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan DNA Microarray Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia DNA Microarray Market

  • 12.1. Australia DNA Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia DNA Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia DNA Microarray Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia DNA Microarray Market

  • 13.1. Indonesia DNA Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia DNA Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia DNA Microarray Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea DNA Microarray Market

  • 14.1. South Korea DNA Microarray Market Overview
  • 14.2. South Korea DNA Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea DNA Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea DNA Microarray Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe DNA Microarray Market

  • 15.1. Western Europe DNA Microarray Market Overview
  • 15.2. Western Europe DNA Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe DNA Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe DNA Microarray Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK DNA Microarray Market

  • 16.1. UK DNA Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK DNA Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK DNA Microarray Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany DNA Microarray Market

  • 17.1. Germany DNA Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany DNA Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany DNA Microarray Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France DNA Microarray Market

  • 18.1. France DNA Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France DNA Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France DNA Microarray Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy DNA Microarray Market

  • 19.1. Italy DNA Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy DNA Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy DNA Microarray Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain DNA Microarray Market

  • 20.1. Spain DNA Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain DNA Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain DNA Microarray Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe DNA Microarray Market

  • 21.1. Eastern Europe DNA Microarray Market Overview
  • 21.2. Eastern Europe DNA Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe DNA Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe DNA Microarray Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia DNA Microarray Market

  • 22.1. Russia DNA Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia DNA Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia DNA Microarray Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America DNA Microarray Market

  • 23.1. North America DNA Microarray Market Overview
  • 23.2. North America DNA Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America DNA Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America DNA Microarray Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA DNA Microarray Market

  • 24.1. USA DNA Microarray Market Overview
  • 24.2. USA DNA Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA DNA Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA DNA Microarray Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada DNA Microarray Market

  • 25.1. Canada DNA Microarray Market Overview
  • 25.2. Canada DNA Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada DNA Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada DNA Microarray Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America DNA Microarray Market

  • 26.1. South America DNA Microarray Market Overview
  • 26.2. South America DNA Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America DNA Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America DNA Microarray Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil DNA Microarray Market

  • 27.1. Brazil DNA Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil DNA Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil DNA Microarray Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East DNA Microarray Market

  • 28.1. Middle East DNA Microarray Market Overview
  • 28.2. Middle East DNA Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East DNA Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East DNA Microarray Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa DNA Microarray Market

  • 29.1. Africa DNA Microarray Market Overview
  • 29.2. Africa DNA Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa DNA Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa DNA Microarray Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. DNA Microarray Market Competitive Landscape And Company Profiles

  • 30.1. DNA Microarray Market Competitive Landscape
  • 30.2. DNA Microarray Market Company Profiles
    • 30.2.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. DNA Microarray Market Other Major And Innovative Companies

  • 31.1. PerkinElmer Inc.
  • 31.2. Illumina Inc.
  • 31.3. bioMerieux SA
  • 31.4. Schott AG
  • 31.5. Bio-Rad Laboratories Inc.
  • 31.6. QIAGEN N.V.
  • 31.7. Bioneer Corporation
  • 31.8. CapitalBio Technology Co. Ltd.
  • 31.9. Eurofins Genomics LLC
  • 31.10. Savyon Diagnostics Ltd.
  • 31.11. Oxford Gene Technology
  • 31.12. Sengenics Corporation LLC
  • 31.13. Affymetrix
  • 31.14. BioCat GmbH
  • 31.15. Scienion AG

32. Global DNA Microarray Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The DNA Microarray Market

34. Recent Developments In The DNA Microarray Market

35. DNA Microarray Market High Potential Countries, Segments and Strategies

  • 35.1 DNA Microarray Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 DNA Microarray Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 DNA Microarray Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer